WeSearch

STAT+: Novo underwhelmed by drug it once fought Pfizer for

Meghana Keshavan· ·3 min read · 0 reactions · 0 comments · 9 views
STAT+: Novo underwhelmed by drug it once fought Pfizer for

Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news

Original article
STAT · Meghana Keshavan
Read full at STAT →
Opening excerpt (first ~120 words) tap to expand

STAT PlusNewsletterThe Readout Novo underwhelmed by drug it once fought Pfizer for Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news Manage alerts for this article Email this article Share this article LISELOTTE SABROE/Scanpix/AFP via Getty Images By Meghana KeshavanJune 8, 2026 Biotech Correspondent Meghana Keshavan[email protected]Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Gene therapies can now cure disease, but America still hasn’t figured out how to pay for them.

…

Excerpt limited to ~120 words for fair-use compliance. The full article is at STAT.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from STAT

STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
STAT·9
Opinion: How the Amish think about vaccines, health care costs, and much more
STAT·17
Opinion: I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous action
STAT·16
STAT+: Newer GLP-1s, pushback on research cuts, and a protest
STAT·20
STAT+: Up and down the ladder: The latest comings and goings
STAT·15
STAT+: Will Makary’s FDA voucher program survive?
STAT·18